← Leaderboards
Janghoo Lim
Yale University
$15,406,372
Attributed
$15,406,372
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.2M · FY2009–25$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,406,372 · 8
By mechanism
R01$14,049,826 · 5
R00$720,689 · 1
R21$460,625 · 1
K99$175,232 · 1
Top collaborators
No co-investigators on record.
Most similar at Yale University
Same institution · by research overlap
- Robert Hill$3,859,562
- Tiffany Werlyne Todd$63,401
- Benjamin Edward Sanders$83,488
- Ashley Owens$83,496
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposInsightMolecularIn VivoBiochemicalNeurodegenerative DisordersProteinsBehavioralPathogenesisPhenotypePathway InteractionsAffectTherapeutic InterventionFunctional DisorderKnockout MiceNemo-Like KinaseProtein-Serine-Threonine KinasesLeadPathologicGeneticPolyglutamineNeuronsAllelesOnset Of Illness
Grant awards (35)
Evaluation of a novel NLK function in lysosome biogenesis and neurodegenerative diseases$792,034
R01 · FY2025 · AG · contact PI
Investigation of the role of ATXN1 in oligodendroglia and neurodegenerative diseases$668,392
R01 · FY2025 · AG · contact PI
Evaluation of a novel NLK function in lysosome biogenesis and neurodegenerative diseases$808,198
R01 · FY2024 · AG · contact PI
Investigation of the role of ATXN1 in oligodendroglia and neurodegenerative diseases$698,909
R01 · FY2024 · AG · contact PI
Microglial regulation of Progranulin levels$623,237
R01 · FY2024 · AG · contact PI
Investigation of the role of ATXN1 in oligodendroglia and neurodegenerative diseases$10,091
R01 · FY2024 · AG · contact PI
Evaluation of a novel NLK function in lysosome biogenesis and neurodegenerative diseases$808,198
R01 · FY2023 · AG · contact PI
Investigation of the role of ATXN1 in oligodendroglia and neurodegenerative diseases$686,219
R01 · FY2023 · AG · contact PI
Microglial regulation of Progranulin levels$623,237
R01 · FY2023 · AG · contact PI
Investigation of the role of ATXN1 in oligodendroglia and neurodegenerative diseases$72,920
R01 · FY2023 · AG · contact PI
Evaluation of a novel NLK function in lysosome biogenesis and neurodegenerative diseases$808,198
R01 · FY2022 · AG · contact PI
Investigation of the role of ATXN1 in oligodendroglia and neurodegenerative diseases$686,219
R01 · FY2022 · AG · contact PI
Microglial regulation of Progranulin levels$623,237
R01 · FY2022 · AG · contact PI
Investigation of the role of ATXN1 in oligodendroglia and neurodegenerative diseases$25,125
R01 · FY2022 · AG · contact PI
Evaluation of a novel NLK function in lysosome biogenesis and neurodegenerative diseases$808,198
R01 · FY2021 · AG · contact PI
Microglial regulation of Progranulin levels$623,237
R01 · FY2021 · AG · contact PI
Microglial regulation of Progranulin levels$623,237
R01 · FY2020 · AG · contact PI
Regulation of inhibitory interneuron development$209,375
R21 · FY2020 · MH · contact PI
Cellular and Molecular Studies of SBMA Neuromuscular Disease$364,219
R01 · FY2019 · NS · contact PI
Regulation of inhibitory interneuron development$251,250
R21 · FY2019 · MH · contact PI
Cellular and Molecular Studies of SBMA Neuromuscular Disease$418,750
R01 · FY2018 · NS · contact PI
Cellular and Molecular Studies of SBMA Neuromuscular Disease$364,219
R01 · FY2018 · NS · contact PI
Investigating the Pathogenesis of Cerebellar Neurodegeneration$364,219
R01 · FY2018 · NS · contact PI
Investigating the Pathogenesis of Cerebellar Neurodegeneration$364,219
R01 · FY2017 · NS · contact PI
Cellular and Molecular Studies of SBMA Neuromuscular Disease$364,219
R01 · FY2017 · NS · contact PI
Cellular and Molecular Studies of SBMA Neuromuscular Disease$364,219
R01 · FY2016 · NS · contact PI
Investigating the Pathogenesis of Cerebellar Neurodegeneration$364,219
R01 · FY2016 · NS · contact PI
Cellular and Molecular Studies of SBMA Neuromuscular Disease$364,219
R01 · FY2015 · NS · contact PI
Investigating the Pathogenesis of Cerebellar Neurodegeneration$364,219
R01 · FY2015 · NS · contact PI
Investigating the Pathogenesis of Cerebellar Neurodegeneration$364,219
R01 · FY2014 · NS · contact PI
The role of Nemo-like kinase in neurodegeneration$232,359
R00 · FY2012 · NS · contact PI
The role of Nemo-like kinase in neurodegeneration$239,330
R00 · FY2011 · NS · contact PI
The role of Nemo-like kinase in neurodegeneration$249,000
R00 · FY2010 · NS · contact PI
The role of Nemo-like kinase in neurodegeneration$87,616
K99 · FY2010 · NS · contact PI
The role of Nemo-like kinase in neurodegeneration$87,616
K99 · FY2009 · NS · contact PI